GENOTROPIN: payments to doctors
Payments that named GENOTROPIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $389K
- Providers
- 2,420
- Transactions
- 8,467
- Average per transaction
- $46
The per-transaction average — $46 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,420 providers the average total is $161, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $369,839 | 95.1% |
| PBG Puerto RICO LLC | $16,567 | 4.3% |
| Pfizer S.a.s. | $1,541 | 0.4% |
| Pfizer Pharmaceuticals LLC | $855 | 0.2% |